AnalystsPaul JengPaul Jeng's Stock Forecasts
AnalystsPaul Jeng
Sectors:
Industries:
Analyst Ranking
Bottom 16%
#4665 out of 5510 analysts
Average Return
-2.4%
Win Rate
43%6 out of 14
Risk vs Reward
Poor
Good
Paul Jeng's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Adagene IncADAG | +72.11% | $1.90 | $3.27 | 2025-11-24 - 2026-09-09 | Strong Buy |
Ideaya Biosciences IncIDYA | +46.26% | $26.22 | $38.35 | 2025-09-18 - 2026-09-09 | Strong Buy |
Immatics NvIMTX | +37.82% | $6.61 | $9.11 | 2025-09-18 - 2026-09-09 | Strong Buy |
Ideaya Biosciences IncIDYA | +24.03% | $30.92 | $38.35 | 2026-02-18 - 2026-09-09 | Strong Buy |
Ideaya Biosciences IncIDYA | +18.55% | $32.35 | $38.35 | 2026-04-14 - 2026-09-09 | Strong Buy |
Paul Jeng Analyst Color
Get additional color on Paul Jeng's coverage of popular stocks
Paul Jeng's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ideaya Biosciences IncIDYA | 4 | Strong Buy | $57.00 | +48.63% | Maintains | a day ago |
Erasca IncERAS | 1 | Strong Buy | $21.00 | +33.76% | Maintains | a month ago |
Coherus Oncology IncCHRS | 1 | Strong Buy | $10.00 | +657.58% | Maintains | a month ago |
Corbus Pharmaceuticals Holdings IncCRBP | 2 | Strong Buy | $45.00 | +407.90% | Reiterates | 4 months ago |
Adagene IncADAG | 2 | Strong Buy | $10.00 | +205.81% | Maintains | 5 months ago |
Context Therapeutics IncCNTX | 2 | Strong Buy | $5.00 | +1,251.35% | Reiterates | 6 months ago |
Immatics NvIMTX | 2 | Strong Buy | $19.00 | +108.56% | Maintains | 10 months ago |
Immunocore Holdings PLCIMCR | 1 | Hold | N/A | N/A | Assumes | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.